Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy.
Target Oncol. 2024 Mar;19(2):175-180. doi: 10.1007/s11523-023-01031-y. Epub 2024 Feb 3.
Target Oncol. 2024.
PMID: 38308662
Free PMC article.
Review.
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma.
Poprach A, Kiss I, Stanik M, Barusova T, Pospisilova L, Fiala O, Kopecky J, Richter I, Melichar B, Studentova H, Lakomy R, Holanek M, Rozsypalova A, Zemanková A, Svoboda M, Buchler T.
Poprach A, et al.
Target Oncol. 2023 Nov;18(6):893-903. doi: 10.1007/s11523-023-01013-0. Epub 2023 Nov 13.
Target Oncol. 2023.
PMID: 37957520
Item in Clipboard
Cite
Cite